Furthermore, global lipodystrophic Bscl2−/−mice exhibit hypertrophic cardiomyopathy with reduced cardiac steatosis, and mice with cardiac-specific deletion of Bscl2 developed systolic dysfunction with dilation, through excessive lipid catabolism (Zhou et al. 2022). The gene discussed is BSCL2; the disease is hypertrophic cardiomyopathy.